Adaptive licensing: A new approach for authorizing medicines

At the 20th Congress of the European Hematology Association (EHA), Stephen O’Brien, BSc (Hons), PhD, MBChB, FRCP, FRCPath, of the University of Newcastle, Newcastle upon Tyne, UK, explains the process of adaptive licensing of new medicines, which aims to improve timely access for patients to new medicines.

Share this video  
12th June 2015